AZD6765 for Treatment Resistant Depression

A Phase IIa, Multi-Center, Randomized, Double-blind, Placebo-controlled, Parallel-Group Study to Assess the Antidepressant Effect and Onset of Effect of AZD6765 in Treatment-Resistant Major Depressive Disorder Patients

The purpose of this study is to determine whether treatment with AZD6765 will have an antidepressant effect with patients who have treatment resistant depression.

Inclusion Criteria:

• Diagnosis of Depression
• Inadequate response to an adequate course of antidepressants

Exclusion Criteria:

• Psychiatric disorder other than depression
• Pregnancy or lactation
• Current diagnosis of cancer